این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Journal of Kerman University of Medical Sciences، جلد ۱۲، شماره ۲، صفحات ۹۳-۹۸
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Evaluation of Hearing Threshold in Patients with Beta Thalasemia Major Receiving Regular ChelationTherapy with Desferrioxamine (DFO)
چکیده انگلیسی مقاله The aim of this study was the evaluation of hearing threshold in patients with beta thalasemia major. For this purpose, 178 patients who were under regular chelation therapy with desferrioxamine (DFO) were selected and underwent ear, nose, throat examinations and audiological evaluations. Patients were between 4 to 25 years old and 54.9% were male and 45.1% were female. Three patients were excluded from the study due to middle ear disease and tympanic membrane perforation. Mean hearing threshold was 12.46db. The incidence of hearing loss in speech frequencies was 1.8% and there was a correlation between hearing threshold increase and the duration of disease and desferrioxamine consumption. But no correlation was found between hearing threshold and serum ferritin level (mean 4046 ng/ml) or DFO dose (mean=38.68mg/kg/day).
کلیدواژه‌های انگلیسی مقاله Hearing threshold, Beta thalasemic major, Desferrioxamine
نویسندگان مقاله k مظفری نیا |
associate professor of ent

z فرهمند |
assistant professor of pediatrics

m قزوینی |
resident of ent, school of medicine, kerman university of medical sciences and health services, kerman , iran.
سازمان اصلی تایید شده: دانشگاه علوم پزشکی کرمان (Kerman university of medical sciences)

نشانی اینترنتی http://jkmu.kmu.ac.ir/article_32016_2eaf315a4210f929bda65bfc46d648bc.pdf
فایل مقاله اشکال در دسترسی به فایل - ./files/site1/rds_journals/93/article-93-405270.pdf
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات